Lv2
120 积分 2023-11-01 加入
Abstract PD8-05: Overall survival (OS) results from the phase III PHENIX trial of HER2+ metastatic breast cancer treated with pyrotinib plus capecitabine
11小时前
求助中
Abstract PD8-05: Overall survival (OS) results from the phase III PHENIX trial of HER2+ metastatic breast cancer treated with pyrotinib plus capecitabine
13小时前
求助中
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
14小时前
已完结
Postoperative radiotherapy in women with early operable breast cancer (Scottish Breast Conservation Trial): 30-year update of a randomised, controlled, phase 3 trial
4个月前
已完结
Postoperative radiotherapy in women with early operable breast cancer (Scottish Breast Conservation Trial): 30-year update of a randomised, controlled, phase 3 trial
4个月前
已完结
Multidisciplinary Review of Intraductal Papilloma of the Breast can Identify Patients who may Omit Surgical Excision
4个月前
已完结
PD-L1 and B7-H3 are Effective Prognostic Factors and Potential Therapeutic Targets for High-Risk Thyroid Cancer
5个月前
已完结
Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001
5个月前
已完结
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
10个月前
已完结
皖公网安备34019202002308
